- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9: a view beyond the canonical cholesterol lowering impact
Authors
Keywords
Adipose tissue, Brain, Inflammation, Pancreas, Platelet, PCSK9
Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-19
DOI
10.1016/j.ajpath.2021.04.016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study
- (2021) Donald Lyall et al. Archives of Medical Science
- New Insight Into Metformin-Induced Cholesterol-Lowering Effect Crosstalk Between Glucose and Cholesterol Homeostasis via ChREBP (Carbohydrate-Responsive Element-Binding Protein)-Mediated PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Regulation
- (2021) Die Hu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dynamin-related protein 1 inhibition reduces hepatic PCSK9 secretion
- (2021) Maximillian A Rogers et al. CARDIOVASCULAR RESEARCH
- Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators
- (2020) Dongling Liu et al. BIOCHEMICAL PHARMACOLOGY
- Cognition After Lowering LDL-Cholesterol With Evolocumab
- (2020) Baris Gencer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- LEPTIN, RESISTIN, AND PCSK9 – THE ROLE OF STAT3
- (2020) Chiara Macchi et al. AMERICAN JOURNAL OF PATHOLOGY
- Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice
- (2020) Damien Garçon et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion
- (2020) Shi-jun Deng et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation
- (2020) Elena Dozio et al. MEDIATORS OF INFLAMMATION
- Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
- (2020) Thorsten M. Leucker et al. Journal of the American Heart Association
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
- (2020) Emma M. O’Connell et al. Frontiers in Neuroscience
- Hydrogen Sulfide Accumulates LDL Receptor Precursor via Downregulating PCSK9 in HepG2 Cells
- (2020) Yong Huang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- PCSK9 and LRP5 in macrophage lipid internalization and inflammation
- (2020) Lina Badimon et al. CARDIOVASCULAR RESEARCH
- PCSK9 Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36
- (2020) Zhiyong Qi et al. CIRCULATION
- PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes “DAMP”
- (2020) Roy L. Silverstein CIRCULATION
- PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
- (2020) Gabriella di Mauro et al. DRUG SAFETY
- PCSK9 is Expressed in Human Visceral Adipose Tissue and Regulated by Insulin and Cardiac Natriuretic Peptides
- (2019) Marica Bordicchia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apolipoprotein E/Aβ Complex Accumulates in AD Cortical Synapses via apoE Receptors and Is Enhanced by APOE4
- (2019) Tina Bilousova et al. AMERICAN JOURNAL OF PATHOLOGY
- Efficacy and safety of proprotein convertase subtilisin/kexin 9 inhibitors in people with diabetes and dyslipidaemia
- (2019) Wieneke Dijk et al. DIABETES OBESITY & METABOLISM
- Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
- (2019) Maria Pia Adorni et al. Frontiers in Aging Neuroscience
- PCSK9 inhibition and inflammation: A narrative review
- (2019) Massimiliano Ruscica et al. ATHEROSCLEROSIS
- Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines
- (2019) Shijie Liu et al. CARDIOVASCULAR RESEARCH
- Lipid lowering and Alzheimer disease risk: A mendelian randomization study
- (2019) Dylan M. Williams et al. ANNALS OF NEUROLOGY
- Surf4 regulates expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) but is not required for PCSK9 secretion in cultured human hepatocytes
- (2019) Yishi Shen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages
- (2018) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
- (2018) Lorenzo Da Dalt et al. EUROPEAN HEART JOURNAL
- PCSK9 as a Positive Modulator of Platelet Activation
- (2018) Marina Camera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Beyond LDL: What Role for PCSK9 in Triglyceride-Rich Lipoprotein Metabolism?
- (2018) Wieneke Dijk et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PCSK9 induces a pro-inflammatory response in macrophages
- (2018) Chiara Ricci et al. Scientific Reports
- A Mendelian randomization study of the effects of blood lipids on breast cancer risk
- (2018) Christoph Nowak et al. Nature Communications
- The cargo receptor SURF4 promotes the efficient cellular secretion of PCSK9
- (2018) Brian T Emmer et al. eLife
- Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals
- (2018) Chiara Macchi et al. European Journal of Preventive Cardiology
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study
- (2017) Eliano P. Navarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response
- (2017) Teik Chye Ooi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction
- (2017) Hua Sun et al. JOURNAL OF LIPID RESEARCH
- Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
- (2017) M. Ruscica et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- PCSK9 regulates apoptosis in human lung adenocarcinoma A549 cells via endoplasmic reticulum stress and mitochondrial signaling pathways
- (2017) Xiaohui Xu et al. Experimental and Therapeutic Medicine
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice
- (2017) Hui Wang et al. Scientific Reports
- PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
- (2017) Andrea Baragetti et al. European Journal of Preventive Cardiology
- Evaluation of plasma PCSK9 concentrations, transcript of LDL receptor, as well as the total number of monocyte LDL receptors in acute coronary syndrome patients
- (2016) Paweł Burchardt et al. Cardiology Journal
- Effect of Leptin Replacement on PCSK9 inob/obMice and Female Lipodystrophic Patients
- (2016) Amy E. Levenson et al. ENDOCRINOLOGY
- Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer’s Disease
- (2016) Francesca Zimetti et al. JOURNAL OF ALZHEIMERS DISEASE
- Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidence
- (2016) Nicola Ferri et al. Translational Research
- Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
- (2015) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse LiverSignificance
- (2015) Annie Demers et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Role of PCSK9 beyond liver involvement
- (2015) Bertrand Cariou et al. CURRENT OPINION IN LIPIDOLOGY
- Local effects of human PCSK9 on the atherosclerotic lesion
- (2015) Ilaria Giunzioni et al. JOURNAL OF PATHOLOGY
- The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion
- (2014) Camilla Gustafsen et al. Cell Metabolism
- Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor–Dependent and –Independent Mechanisms
- (2014) Shirya Rashid et al. CIRCULATION
- Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
- (2014) Susan Kühnast et al. JOURNAL OF LIPID RESEARCH
- Variable effects of gender and Western diet on lipid and glucose homeostasis in aged PCSK9-deficient C57BL/6 mice 性别与西方饮食对CSK9基因缺陷的PC57BL/6老龄小鼠的脂质以及葡萄糖内稳态的不同影响
- (2014) Majambu Mbikay et al. Journal of Diabetes
- Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1
- (2013) Cédric Le May et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells
- (2013) Emile Levy et al. ATHEROSCLEROSIS
- Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding
- (2013) Hong-mei Gu et al. JOURNAL OF LIPID RESEARCH
- SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion
- (2013) Xiao-Wei Chen et al. eLife
- Proprotein Convertase Subtilisin/Kexin Type 9 Interacts With Apolipoprotein B and Prevents Its Intracellular Degradation, Irrespective of the Low-Density Lipoprotein Receptor
- (2012) Hua Sun et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The M2 Module of the Cys-His-rich Domain (CHRD) of PCSK9 Protein Is Needed for the Extracellular Low-density Lipoprotein Receptor (LDLR) Degradation Pathway
- (2012) Yascara Grisel Luna Saavedra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice
- (2012) Ding Ai et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein Receptor Suppression Mediated in Part by Proprotein Convertase Subtilisin/Kexin Type 9
- (2012) Michelle Melone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue
- (2011) Anna Roubtsova et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors
- (2011) Øystein L. Holla et al. JOURNAL OF LIPID RESEARCH
- PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke
- (2011) Estelle Rousselet et al. JOURNAL OF LIPID RESEARCH
- Increased Secretion of Lipoproteins in Transgenic Mice Expressing Human D374Y PCSK9 Under Physiological Genetic Control
- (2010) Bronwen Herbert et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain
- (2010) Mali Liu et al. JOURNAL OF LIPID RESEARCH
- Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
- (2010) Bin Dong et al. JOURNAL OF LIPID RESEARCH
- Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia
- (2009) Cédric Le May et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PCSK9 is expressed in pancreatic δ-cells and does not alter insulin secretion
- (2009) Cédric Langhi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Central nervous system: cholesterol turnover, brain development and neurodegeneration
- (2009) John M. Dietschy BIOLOGICAL CHEMISTRY
- PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities
- (2009) Majambu Mbikay et al. FEBS LETTERS
- Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation
- (2009) Steve Poirier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
- (2009) Jungsu Kim et al. NEURON
- PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1
- (2008) Mary Cabell Jonas et al. EMBO REPORTS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started